Clinical efficacy of high dose monotherapy of oral dihydroartemisinin in uncomplicated falciparum malaria in Viet Nam

Japanese Journal of Infectious Diseases

Volumn 60, Issue 4, 2007, Pages 161-166

  Thuy, Le Thi Diem ^a,b   Na Bangchang, Kesara ^a   Hung, Le Ngoc ^b   Chong, Mien Tieu ^c   Van Thang, Nguyen ^d   Van Binh, Nguyen ^e   Danh, Phan Thi ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b CHO RAY HOSPITAL   (Viet Nam)

^c Bac Binh District Hospital   (Viet Nam)

^d Mepu Region Health Post   (Viet Nam)

^e 11th Rubber Plantation Health Post ^*  (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ; EUPHAQUINE; MEFLOQUINE; PIPERAQUINE; PRIMAQUINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FEVER; FOLLOW UP; HUMAN; INFECTION RATE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; PARASITEMIA; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; RELAPSE; SURVIVAL; VIET NAM;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; PLASMODIUM FALCIPARUM; SESQUITERPENES; TREATMENT OUTCOME; VIETNAM;

EID: 34548457596     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Health Organization (1995): WHO Model Prescribing Information: Drugs used in Parasitic Diseases. 2nd ed. World Health Organization, Geneva, Switzerland.
2. de Vries, P.J. and Dien, T.K. (1996): Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drug, 52, 818-836.
3. Brossi, A., Venugopalan, B., Gerpe, L.D., et al. (1988): Arteether, a new antimalarial. drug: synthesis and antimalarial properties. J. Med. Chem., 31, 645-650.
4. Davis, T.M.E., Karunajeewa, H.A. and Ilett, K.F. (2005): Artemisinin-based combination therapies for uncomplicated malaria. Med. J. Australia, 182, 181-185.
5. Looareesuwan, S., Viravan, C., Vanijanonta, S., et al. (1992): Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet, 339, 821-824.
6. Karbwang, J., Na-Bangchang, K., Thanavibul, A., et al. (1998): Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum. malaria. Ann. Trop. Med. Parasitol., 92, 31-36.
7. Looaresuwan, S., Wilairatana, P., Vanijanonta, S., et al. (1996): Treatment of acute uncomplicated falciparum malaria with oral dihydroartemisinin. Ann. Trop. Med. Parasitol., 90, 21-28.
8. Hien, T.T. and White, N.J. (1993): Qinghaosu. Lancet, 341, 603-608.
9. Alin, M.H., Kihamia, C.M., Bjorkman, A., et al. (1995): Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine and mefloquine. Am. J. Trop. Med. Hyg., 53, 639-645.
10. Alin, M.H., Ashton, M., Kihamia, C.M., et al. (1996): Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg., 90, 61-65.
11. Khanh, N.X., de Vries, P.J., Ha, L.D., et al. (1999): Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for falciparum malaxia. Antimicrob. Agents Chemother., 43, 690-692.
12. Sy, N.D., Dao, D.H., Nguyen, P.D., et al. (1993): Treatment of malaria in Viet Nam with oral artemisinin. Am. J. Trop. Med. Hyg., 48, 398-402.
13. Bich, N.N., de Vries, P.J., Hung, L.N., et al. (1996): Efficacy and tolerance of artemisinin in short combination regimens for the treatment of uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg., 55, 438-443.
14. Hung, L.N., de Vries, P.J., Diem Thuy, L.T., et al. (1997): Single dose artemisinin-mefloquine versus mefloquine alone for uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg., 91, 191-194.
15. Li, G.Q., Guo, X.B., Fu, L.C., et al. (1994): Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg., 88 (Suppl. 1), 5-6.
16. Wilairatana, P., Chanthavanich, P., Singhasivanon, P., et al. (1998): A comparison of three different dihydroartemisinin formulations for the treatment of acute uncomplicated falciparum malaria in Thailand. Int. J. Parasitol., 28, 1213-1218.
17. Na-Bangchang, K., Congpuong, K., Ubalee, R., et al. (1997): Pharmacokinetics and ex-vivo antimalarial activity of sera following a single dose of dihydroartemisinin in healthy Thai males. Southeast Asian J. Trop. Med. Public Health, 28, 731-735.
18. Na-Bangchang, K., Congpuong, K., Hung, L.N., et al. (1998): A simple high-performance liquid chromatography with electrochemical detection method for simultaneous determination of artesunate and dihydroartemisinin in biological fluid. J. Chromatogr. B, 708, 201-207.
19. Hung, L.N., Na-Bangchang, K., Diem Thuy, et al. (1999): Pharmacokinetics of a single oral dose of dihydroartemisinin in Vietnamese healthy volunteers. Southeast Asian J. Trop. Med. Public Health, 30, 11-16.
20. Wongsrichanalai, C., Dung, N.T., Trung, T.N., et al. (1997): In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials. Acta Tropica, 63, 151-158.
21. Benakis, A., Paris, M., Anh, T.K., et al. (1996): Pharmacokinetic study of dihydroartemisinin in malaria patients in Viet Nam. Jpn. J. Trop. Med. Hyg., 24 (Suppl. 1), 71-76.
22. White, N.J. (1997): Minireview: assessment of the pharmacodynamic properties of antimatarial drugs in vivo. Antimicrob. Agents Chemother., 41, 1413-1422.
23. Inselberg, J. (1985): Induction and isolation of artemisinin-resistant mutants of Plasmodium falciparum. Am. J. Trop. Med. Hyg., 34, 417-418.
24. Basco, L.K. and Le Bras, J. (1993): In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg., 49, 301-307.
25. World Health Organization (1997): Report on Interregional Meeting on Malaria Control with Emphasis on Drug Resistance. Manila, Philippines, 21-24 October 1996. Unpublished WHO document. Regional Office for the Western Pacific, (WP)MAL/ICP/CTD/011-E, Report Series No. RS/96/GE/ 12(PHL).
26. Giao, P.T., Binh, T.Q., Kager, K.A., et al. (2001): Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy ? Am. J. Trop. Med. Hyg., 65, 690-695.
27. White, N.J. (1998): Preventing antimalarial drugs resistance through combination. Drugs Res. Update, 1, 3-9.
28. Nosten, F., van Vugt, M., Price, R., et al. (2000): The effects of combining artesuante with mefloquine on the incidence of falciparum malaria and the evolution of drug resistance. Lancet, 356, 297-302.
29. Price, R.N., Nosten, T., Luxemburger, C., et al. (1996): Effects of artemisinin derivatives on malaria transmissibility. Lancet, 347, 1654-1658.
30. Gupta, S., Thapar, M.M., Wernsdorfer, W.H., et al. (2002): In vitro interaction of artemisinin with atovaquone, quinine and mefloquine against Plasmodium falciparum. Antimicrob. Agents Chemother., 46, 1510-1515